Tumour necrosis factor α inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Concise reports

Tumour necrosis factor α inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients

Authors

C Pritchard Rheumatology Specialty Center, 2400 Maryland Road, Suite 40, Willow Grove, PA 19090, USA PubMed articles Google scholar articles
K Nadarajah Rheumatology Specialty Center, 2400 Maryland Road, Suite 40, Willow Grove, PA 19090, USA PubMed articles Google scholar articles

Correspondence to:
Dr K Nadarajah;
knadarajahamh.org

Citation

Pritchard C, Nadarajah K

Tumour necrosis factor α inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients

Annals of the Rheumatic Diseases 2004;63:318-320.

Publication history

Accepted May 12, 2003
First published February 12, 2004.

Online issue publication

January 09, 2022

Copyright information

Copyright 2004 by Annals of the Rheumatic Diseases